Retroseptal Transconjunctival Blepharoplasty for GIR

NCT ID: NCT04538716

Last Updated: 2023-11-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-08-01

Study Completion Date

2023-11-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The tear trough deformity is a challenging cosmetic condition.surgical treatment and filling are good treatment options

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Procedure is lower eyelid transconjunctival Blepharoplasty associated with stromal vascular fraction gel (SVF-gel) or fat transposition

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Eyelid Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SVF-gel

Transconjunctival blepharoplasty associated with associated with stromal vascular fraction gel (SVF-gel)

Group Type EXPERIMENTAL

transconjunctival lower blepharoplasty

Intervention Type PROCEDURE

transconjunctival lower blepharoplasty associated with stromal vascular fraction gel (SVF-gel)

fat transposition

Transconjunctival blepharoplasty associated with fat transposition

Group Type EXPERIMENTAL

transconjunctival lower blepharoplasty

Intervention Type PROCEDURE

transconjunctival lower blepharoplasty associated with stromal vascular fraction gel (SVF-gel)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

transconjunctival lower blepharoplasty

transconjunctival lower blepharoplasty associated with stromal vascular fraction gel (SVF-gel)

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* tear trough deformity

Exclusion Criteria

* Eyelid diseases and previous eyelid surgery
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Benha University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Tarek Roshdy mohamed Mahgoub ELhamaky

lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

TAREK ELHAMAKY, MD

Role: PRINCIPAL_INVESTIGATOR

Benha university faculty of medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

INMC

Abu Dhabi, , United Arab Emirates

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Arab Emirates

References

Explore related publications, articles, or registry entries linked to this study.

Elhamaky TR. Orbital fat graft retroseptal transconjunctival blepharoplasty for treatment of groove in the infraorbital region. Int Ophthalmol. 2024 May 6;44(1):217. doi: 10.1007/s10792-024-03148-z.

Reference Type DERIVED
PMID: 38705907 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Hamaky6

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Lacrimal Deroofing for Epiphora
NCT06983717 COMPLETED